Understanding New Treatment Options for Patients with Relapsed/Refractory Multiple Myeloma

There has been tremendous growth over the years in terms of treatment options for patients with multiple myeloma. That growth has extended to patients in the relapsed and refractory setting who often face an even more complex disease than patients with traditional multiple myeloma.This is as a result of patients with relapsed or refractory multiple [...]

Published December 15, 2020 at 04:50PM. Read full article at Stem Cells in the News Portal.